Clinical Trials Browser

Tiragolumab × Tumor-Agnostic × 90 days × Clear all

NCT05862285 2026-05-12

UmbrellaMAX

Phase 3 Recruiting

Neoplasms

NCT05394337 2026-05-05

Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma

Phase 1/2 Recruiting

Neoplasms